Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3317999787b3b255a876cc66d7762644 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-24007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-20 |
filingDate |
2007-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb4c70502fd15735ea951c9200b90af7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7d823755b1a302acce749bc6a8ef9ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1f331996afb405a18ed10c8b268cd90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bf85308778e15312c99d259eaf5afa4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f668903f59f1ea49cce1136e21723b10 |
publicationDate |
2008-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20080093142-A |
titleOfInvention |
Compositions and Methods for Treating Collagen Mediated Diseases |
abstract |
The present invention relates to a drug comprising a combination of collagenase I and collagenase II highly purified from Clostridium histolyticum . The drug has a purity of at least 95% and comprises collagenase I and collagenase II in a ratio of about 1: 1. The present invention further describes an improved fermentation and purification method for the preparation of the drug. |
priorityDate |
2006-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |